glp-1 drug tirzepatide Hair loss with drugs is rare, but real, studies find FDA says shortage of GLP-1

The CIR Expert Panel has evaluated the scientific data and found this ingredient to be safe, non-irritating, and non-sensitizing at concentrations up to 5% (it's even approved by the FDA as an OTC eye drop ingredient)

10.4236/ojst.2014.44031 61

Depending on the severity, Trichophagia can cause medical complications such as a large mass of undigested hair in the gastrointestinal tract known as a Trichobezoar

Tubal flushing with oil-based contrast medium (Lipiodol ) If couples affected by endometriosis wish to conceive without IVF, fallopian tube patency should be assessed, as endometriosis-associated adhesions and anatomical distortion can disrupt tubal function and hydrosalpinges are more common in endometriosis

The central research question guiding this analysis is: Do GLP-1 agonists represent a genuine game-changing breakthrough in obesity treatment, or are they an overhyped intervention with significant practical limitations that may limit their real-world impact